Toxicology Reagent CEDIA® Amphetamines (AMP) / Ecstasy (MDMA) CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Toxicology Reagent
Brand: CEDIA®

REAGENT, IMMUNOASSAY CEDIA AMPETHAMINE/ECSTASY 65ML D/S

McKesson #

1254908

Manufacturer #

100103

Brand

CEDIA®

Manufacturer

Microgenics

Country of Origin

Unknown

Application

Toxicology Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Urine Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Name

Amphetamines (AMP) / Ecstasy (MDMA)

Test Type

2-Drug Panel

UNSPSC Code

41116007

Volume

65 mL

The CEDIA® Amphetamines/Ecstasy assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative assay of amphetamines and ecstasy in human urine
The CEDIA Amphetamines/Ecstasy assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
Qualitative or semi-quantitative options for results
Excellent correlation to GC/MS